The Life Participation Scale for Attention-Deficit/Hyperactivity Disorder-Child Version: Psychometric properties of an adaptive change instrument

Journal of Child and Adolescent Psychopharmacology

Volumn 17, Issue 6, 2007, Pages 831-841

  Saylor, Keith ^a   Buermeyer, Curt ^a   Sutton, Virginia ^b   Faries, Douglas ^b   Khan, Sajjad ^b   Schuh, Kory ^b  

^a NeuroScience Inc   (United States)

^b ELI LILLY AND COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATOMOXETINE; METHYLPHENIDATE; PLACEBO;

ADOLESCENT; ARTICLE; ATTENTION DEFICIT DISORDER; CHILD; CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DEMOGRAPHY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; EMOTION; EMOTIONALITY; EVENING DOSAGE; FACTORIAL ANALYSIS; FEMALE; HUMAN; INTERNAL CONSISTENCY; LIFE PARTICIPATION SCALE; MAJOR CLINICAL STUDY; MALE; MORNING DOSAGE; PSYCHOMETRY; QUALITY OF LIFE; QUESTIONNAIRE; RATING SCALE; SELF CONTROL; SOCIAL EVOLUTION;

EID: 38549121778     PISSN: 10445463     EISSN: None     Source Type: Journal    
DOI: 10.1089/cap.2007.0030     Document Type: Article

References (15)

1. th edition. Washington (DC), American Psychiatric Association, 1994.
2. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, text revision. Washington (DC), American Psychiatric Association, 2000.
3. Cohen J: Statistical Power Analysis for the Behavioral Sciences, 2nd edition. Hillsdale (NJ), Lawrence Erlbaum Associates, 1988, pp 25-26.
4. DuPaul GJ, Power TJ, Anastopoulos AD, Reid R: ADHD Rating Scale IV: Checklists, Norms, and Clinical Interpretation. New York, The Guilford Press, 1998.
5. Faries DE, Yalcin I, Harder D, Heiligenstein JH: Validation of the ADHD Rating Scale as a clinician administered and scored instrument. J Atten Disord 5:39-47, 2001.
6. Guy W: ECDEU Assessment Manual for Psychopharmacology, Revised. Bethesda (Maryland), US Department of Health, Education and Welfare, 1976.
7. Kaufman J, Birmaher B, Brent D, Rao U, Ryan N: Kiddie-Sads-Present and Lifetime Version (K-SADS-PL), version 1.0 of October 1996 edition. The Department of Psychiatry, University of Pittsburgh School of Medicine, 1996.
8. Kelsey DK, Sumner CR, Casat CD, Coury DL, Quintana H, Saylor KE, Sutton VK, Gonzales J, Malcolm SK, Schuh KJ, Allen AJ: Once-daily atomoxetine treatment for children with attention-deficit/hyperactivity disorder, including an assessment of evening and morning behavior: A double-blind, placebo-controlled trial. Pediatrics 114:e1, 2004.
9. Kelsey D, Sutton V, Lewis D, Schuh K, Sumner C, Quintana H: Morning- versus evening-dosed atomoxetine: Effects on core ADHD symptoms. Atlanta (GA), American Psychiatric Association Annual Meeting, 2005 (abstract).
10. Leon AC, Marzuk PM, Portera L: More reliable outcome measures can reduce sample size requirements. Arch Gen Psychiatry 52:867-871, 1995.
11. Newcorn J, Kratochvil C, Allen A, Milton D, Moore R, Michelson D: Atomoxetine and OROS® methylphenidate for the treatment of ADHD: Acute results and methodological issues. Boca Raton (FL), National Institute of Mental Health, New Clinical Drug Evaluation Unit (NCDEU) Annual Meeting, 2005 (abstract).
12. Perrin ES, Aaronson NK, Alonso J, Burman A, Lohr K, Patrick DL, Stein REK: Instrument Review Criteria. Medical Outcomes Trust, 1997.
13. Saylor K, Buermeyer C, Spencer T, and Barkley R: Adaptive changes related to medication treatment of ADHD: Listening to parents of children in clinical trials of a novel nonstimulant medication. J Clin Psych 63:23-28, 2002.
14. Saylor K, Buermeyer C, Sutton V, Thomason C, Michelson D, C: Development of the Life Participation Scale for ADHD: An adaptive change assessment instrument. Boca Raton (FL), National Institute of Mental Health, New Clinical Drug Evaluation Unit (NCDEU) Annual Meeting, 2003 (abstract).
15. Sumner C, Donnelly C, Lopez F, Sutton V, Bakken R, Paczkowski M, Kelsey D: Atomoxetine treatment for pediatric patients with ADHD and comorbid anxiety disorder. Atlanta (GA), American Psychiatric Association Annual Meeting, 2005 (abstract).